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Summary
We demonstrate that c-Jun N-terminal kinase (JNK) responds to substrate stiffness and regulates adherens junction (AJ) formation in
epithelial cells in 2D cultures and in 3D tissues in vitro and in vivo. Rigid substrates led to JNK activation and AJ disassembly, whereas soft
matrices suppressed JNK activity leading to AJ formation. Expression of constitutively active JNK (MKK7-JNK1) induced AJ dissolution
even on soft substrates, whereas JNK knockdown (using shJNK) induced AJ formation even on hard substrates. In human epidermis, basal
cells expressed phosphorylated JNK but lacked AJ, whereas suprabasal keratinocytes contained strong AJ but lacked phosphorylated JNK.
AJ formation was significantly impaired even in the upper suprabasal layers of bioengineered epidermis when prepared with stiffer scaffold
or keratinocytes expressing MKK7-JNK1. By contrast, shJNK1 or shJNK2 epidermis exhibited strong AJ even in the basal layer. The
results with bioengineered epidermis were in full agreement with the epidermis of jnk12/2 or jnk22/2 mice. In conclusion, we propose that
JNK mediates the effects of substrate stiffness on AJ formation in 2D and 3D contexts in vitro as well as in vivo.
Key words: Human primary keratinocytes, Adherens junctions, Intercellular interactions, Substrate rigidity, Bioengineered epidermis, E-cadherin,
b-catenin, p-c-Jun
Introduction
c-Jun N-terminal kinases (JNKs), also known as the stress-
activated protein kinase, belongs to the mitogen-activated protein
kinase (MAPK) superfamily, which also include the ERKs and
the p38 MAPKs. The JNKs family includes three members
JNK1, JNK2 and JNK3. The Jnk1 and Jnk2 genes are expressed
ubiquitously in all tissues, whereas Jnk3 is only expressed in
brain, heart and testis (Davis, 2000). It has been well-established
that JNKs are activated by MAP2 kinases such as MKK-4, MKK-
6 and MKK-7 (Fanger et al., 1997) and regulate cell apoptosis
(Hu et al., 1999; Yu et al., 2004), stress response (Leppa¨ and
Bohmann, 1999) and cell migration (Nasrazadani and Van Den
Berg, 2011). In particular, JNK phosphorylation has been
associated with formation of focal adhesions (FA), cell
migration, cancer progression and metastasis (Huang et al.,
2003; Kimura et al., 2008; Mitra et al., 2011; Nasrazadani and
Van Den Berg, 2011). On the other hand, knocking down JNK1
(Zhang et al., 2011) or JNK2 (Mitra et al., 2011) greatly reduced
tumor cell migration and invasion, possibly by reducing
phosphorylation of the FA adaptor protein, paxillin, ultimately
reducing cell motility (Huang et al., 2003).
Our previous work showed JNK phosphorylated b-catenin and
regulated adherens junction (AJ) formation in human primary
keratinocytes (hKC), epidermoid carcinoma cells (A431) and
epidermoid cervical carcinoma cells (ME180) and intestinal
epithelial cells (Lee et al., 2009; Lee et al., 2011; Naydenov
et al., 2009). Inhibition of JNK activity caused translocation of E-
cadherin/b-catenin complex to cell–cell contact sites, leading to
formation of AJ, dissociation of a-catenin from E-cadherin/b-
catenin complex and actin bundle formation underneath the cell
membrane (Lee et al., 2009; Lee et al., 2011). Besides JNK,
inhibition of its upstream effector Src family kinase (SFK) also
promoted formation of dense AJ in MCF-7 cells (Tsai and Kam,
2009). In addition to mammalian cells, activation of JNK was
reported to result in downregulation of E-cadherin and b-catenin
complex, loss of cell polarity and tumor growth in Drosophila
epithelial cells (Igaki et al., 2006). These data suggest that JNK
activity is involved in AJ formation in various epithelial cell types.
Previous studies have shown that there is cross-talk between
cell–cell and cell–substrate adhesion as manifested by inhibition
of cadherin function upon integrin engagement (Chen and
Gumbiner, 2006; Tsai and Kam, 2009). This delicate balance
between integrin and cadherin signaling was found to be
regulated by substrate rigidity (Tsai and Kam, 2009), which is
known to regulate cell spreading, migration, proliferation, stem
cell differentiation, and tissue maintenance (Buxboim and
Discher, 2010; Guo et al., 2006). Extracellular matrix stiffening
has been shown to increase integrin expression and drive
malignant behavior of tumor cells through Rho-mediated
cytoskeletal tension (Ng and Brugge, 2009; Paszek et al.,
2005). Tumor invasiveness was also associated with reduced E-
cadherin expression and dissolution of AJ (Sawada et al., 2008;
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Siitonen et al., 1996). Recently, we reported that AJ formation/
dissolution is regulated by JNK in a swift and dynamic manner,
revealing a previously unknown link between JNK and AJ (Lee
et al., 2009; Lee et al., 2011).
In the present study, we provide evidence that JNK mediates
the effect of surface rigidity on formation/dissolution of AJ in 2D
cell culture, in 3D bioengineered tissues in vitro as well as in
mouse and human epidermis in vivo. Our results may have
possible implications in understanding epithelial development,
wound healing and cancer progression.
Results
Substrate rigidity influences colony formation of
epidermal keratinocytes and ME180 cells
Previous studies have shown that substrate rigidity regulated cell–
cell adhesion and cell–substrate adhesion, which plays an important
role in cell differentiation, cancer metastasis, and formation and
maintenance of tissues (Guo et al., 2006; Paszek et al., 2005; Tsai
and Kam, 2009; Young et al., 2003). Recent studies from our group
showed that JNK regulated formation of AJ in human epidermal
keratinocytes (hKC) and other epithelial cell lines in a swift manner
(Lee et al., 2009; Lee et al., 2011). In agreement with our previous
results, treatment of hKC with the JNK chemical inhibitor,
SP600125 induced translocation of E-cadherin and b-catenin to
the cell–cell contact sites (Fig. 1A) and actin reorganization into
actin cables right beneath the newly formed AJ (Lee et al., 2009).
On the other hand, the human epidermoid cervical carcinoma cells
(ME180) lacking a-catenin, did not respond to SP600125.
However, introduction of a-catenin (ME180 a-catenin) restored
the responsiveness of these cells to SP600125 (supplementary
material Fig. S1A) suggesting that a-catenin was necessary for AJ
formation in response to JNK inhibition.
Here we hypothesized that JNK may regulate cell–cell
adhesion in a manner that depends on substrate mechanics. To
address this hypothesis, we generated polydimethylsiloxane
(PDMS) substrates of different compliance by varying the ratio
of polymer to crosslinker. Specifically, we employed substrates
with Young’s modulus ranging from 16103 kPa to 16 kPa using
curing ratios ranging from 9:1 to 49:1 (v/v), respectively
(Fig. 1B). As control, we used plastic with Young’s modulus of
2.86106 kPa or glass with Young’s modulus of 6.96107 kPa
(Callister, 2001). Before seeding hKC, substrates were pre-coated
with type I collagen (50 mg/ml) for 12 hours at 4 C˚ followed by
UV-treatment for 4 hours. Measurements of fluorescence
intensity of surface bound FITC-conjugated collagen showed
that similar amounts of collagen were deposited on all surfaces
(Fig. 1C). In agreement, the level of phosphorylated focal
adhesion kinase (p-FAK) at 30 minutes post-seeding was
similar among the substrates, indicating similar levels of initial
cell attachment (supplementary material Fig. S2). Indeed, the
MTT assay showed that similar numbers of cells adhered on each
substrate (n53, P.0.05) (Fig. 1D).
On the other hand, substrate stiffness affected hKC
morphology significantly (Fig. 1E). On plastic, hKC spread and
distributed evenly within 24 hours. However, on the hard PDMS
substrate (16103 kPa) hKC tended to form colonies, and further
aggregated on soft PDMS (16 kPa). As substrate rigidity
decreased the number of single cells decreased and the number
of cells participating in colonies increased (Fig. 1F).
Interestingly, ME180 lacking a-catenin failed to form colonies
but introduction of a-catenin restored the ability of these cells to
cluster into colonies on hard and soft PDMS substrates
(supplementary material Fig. S1B), suggesting that a-catenin
was necessary for AJ formation in response to substrate stiffness,
in agreement with our previous findings (Lee et al., 2011).
AJ formation is regulated by substrate mechanics
To confirm that soft substrates induced AJ formation, we
employed immunostaining for E-cadherin and b-catenin
(Fig. 1G). Plating hKC on PDMS (16103 kPa) induced
localization of E-cadherin and b-catenin at the cell–cell contact
sites indicating AJ formation. Cell aggregation appeared more
compact and the fluorescence staining intensity increased further
on the softer PDMS substrate (16 kPa), indicating an inverse
relationship between substrate rigidity and AJ formation. The
spreading area of cells on soft PDMS was reduced significantly
compared to cells on glass (Fig. 1H). As expected, hKC failed to
form AJ on glass surface, except when JNK activity was inhibited
by treatment of SP600125 (10 mM, 30 minutes).
In contrast to hKC, ME180 cells lacking a-catenin failed to
form AJ either with SP600125 treatment or on PDMS substrates,
as indicated by E-cadherin immunostaining (supplementary
material Fig. S1C). However, introduction of full-length a-
catenin restored the ability of ME180 cells to form AJ upon
SP600125 treatment and on PDMS substrate. Finally,
overexpression of a-catenin-DsRed fusion protein in ME180
cells enabled real-time monitoring of a-catenin translocation to
the newly formed cell–cell contact sites on soft PDMS substrates
(supplementary material Movies 1, 2).
Substrate rigidity affects JNK phosphorylation
Next we examined the effect of substrate mechanics on JNK
phosphorylation. Initially, adhesion of hKC to the collagen-coated
surface induced JNK phosphorylation independent of substrate
rigidity (Fig. 2A). At 2 hours, phosphorylated JNK (p-JNK) levels
decreased on all substrates to about 30–40% (p-JNK1) or 40–50%
(p-JNK2) of the initial level on plastic. At 6 hours, the level of p-
JNK remained constant on plastic but continued to decrease on the
PDMS substrates and by 24 hours, the level of p-JNK was very
low, especially on the soft PDMS substrate (p-JNK1 as % of the
level on plastic at time zero: hard PDMS, 2066%; soft PDMS,
764%; p-JNK2: hard PDMS, 2967%; soft PDMS, 464%,
P,0.05 versus plastic 0 hours) (Fig. 2B,C). Consistently,
decreasing substrate rigidity decreased the level of p-JNK at
24 hours post-seeding in a dose-dependent manner (Fig. 2D,E). In
agreement with p-JNK, the level of p-FAK remained constant on
plastic surface, but decreased on hard and soft PDMS within
24 hours (supplementary material Fig. S2).
However, the total protein levels of E-cadherin and b-catenin
remained unaffected by substrate stiffness (Fig. 2F). Similar
results were observed in ME180 cells. Specifically, the
phosphorylation level of p-JNK1 and p-JNK2 decreased with
decreasing substrate stiffness (supplementary material Fig. S1D)
but the level of E-cadherin and b-catenin remained unchanged
(supplementary material Fig. S1E).
Substrate rigidity regulates AJ formation through JNK
Next we employed both constitutively active and knockdown
strategies to determine whether substrate stiffness affected
AJ formation through JNK. To this end, hKC were transduced
with lentivirus encoding for the fusion protein between JNK1
and its upstream activator, MKK7 (MMK7-JNK1), which
Substrate rigidity and AJ formation 2719
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was previously shown to increase JNK1 phosphorylation
constitutively (Lei et al., 2002). Indeed, expression of
MKK7-JNK1 increased the level of p-JNK1 (Fig. 3A) and
prevented AJ formation even on the PDMS substrates (Fig. 3B),
without affecting the amount of E-cadherin or b-catenin
(Fig. 3A). On the other hand, treatment with SP600125
(10 mM) induced AJ formation (Fig. 3B), suggesting that loss
of AJ in MKK7-JNK1 cells was due to increased JNK activity.
In addition, we employed shRNA to knockdown JNK1, JNK2
or both JNK1/2 in hKC (Fig. 3C). In agreement with SP600125
treatment, shJNK1, shJNK2 or shJNK1/2 hKC formed AJ not
only on hard and soft PDMS but even on glass (Fig. 3D). On the
other hand, the amount of total b-catenin and E-cadherin
remained unchanged (Fig. 3C). These results demonstrate that
the effect of substrate stiffness on cell–cell adhesion and AJ
formation may be mediated through JNK.
Fig. 1. Substrate rigidity
influences colony and AJ
formation of epidermal
keratinocytes. (A) hKC were
cultured on a glass surface in the
presence or absence of SP600125
(10 mM, 30 minutes) and
subsequently immunostained for E-
cadherin (green) and b-catenin
(red). Nucleus was counterstained
with Hoechst dye (blue). View663.
(B) The Young’s modulus of human
acellular dermis and PDMS
substrates of different stiffness were
measured by tensile testing (n53).
The Young’s modulus of glass and
polystyrene were obtained from
Callister (Callister, 2001). (C) The
fluorescence intensity of bound
FITC-conjugated collagen on non-
tissue culture plastic, glass, hard
PDMS and soft PDMS. The data
was normalized to the intensity on
plastic surface (100%) (n53).
(D) Viability of hKC on different
substrates was measured by MTT
assay at 0.5, 2, 6 and 24 hours post-
seeding. Data are presented as
absorbance at 570 nm (n53).
(E) Morphology of hKC on plastic,
hard PDMS or soft PDMS as
indicated. View 106. (F) At
24 hours post-seeding, the cells
were counted and the percentage of
single cells and cells within colonies
was determined (n53); *P,0.001
versus cell without junction on
plastic; #P,0.01 versus cell with
junction on plastic. (G) hKC were
cultured on glass surface, hard
PDMS and soft PDMS for 24 hours
in the presence or absence of
SP600125 (10 mM, 30 minutes) and
subsequently immunostained for E-
cadherin (red) and b-catenin (red).
Nuclei were counterstained with
Hoechst dye (blue). View 636.
(H) At 24 hours post-seeding, the
spreading area of hKC on substrates
of varying stiffness, i.e. glass, hard
PDMS and soft PDMS, was
measured using ImageJ (n53);
*P,0.001 versus glass. Scale bars:
10 mm (A,G); 400 mm (E).
Journal of Cell Science 126 (12)2720
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JNK phosphorylation correlated negatively with AJ
formation in human epidermis
Next we examined the relationship between JNK phosphorylation
and AJ localization in human neonatal foreskin epidermis.
As expected, actively proliferating keratinocytes localized
predominately at the basal layer as indicated by proliferating
cell nuclear antigen (PCNA) staining, while suprabasal cells
stained positive for the differentiation marker, keratin 10
(Fig. 4A). In addition, p-JNK and p-c-Jun were prominently
localized in the basal layer but both were also observed in 2–3
suprabasal layers as well (Fig. 4A). On the other hand,
immunostaining for E-cadherin, b-catenin, a-catenin and F-
actin appeared weak and mostly cytoplasmic in the basal and
immediate suprabasal layers but became intense and highly
localized at cell–cell contact sites in the upper suprabasal layers
(Fig. 4B). Quantification of the fluorescence intensity (arbitrary
units/mm2) of b-catenin at cell–cell contact sites in each
epidermal cell layer showed a clear, negative correlation with
the levels of p-JNK in nucleus (Spearman correlation coefficient,
Rs520.89), suggesting that JNK may regulate AJ formation in a
3D tissue context as well (Fig. 4C).
Substrate mechanics affect JNK activity and AJ formation
in 3D bioengineered tissues
Previous studies indicated that the stratum corneum and dermis are
the major contributors to the mechanical integrity of the skin,
while the live epidermal cell layers are thought to play only minor
role (Magnenat-Thalmann et al., 2002; Pailler-Mattei et al., 2008).
Since basal epidermal cells reside on the stiff dermal substrate,
while suprabasal cells reside on top of another cell layer, it is
plausible that basal cells may experience higher stiffness compared
to suprabasal cells. This stiffness gradient may in turn determine
the gradients of p-JNK, E-cadherin and b-catenin that were
observed across the epidermis. If true, then increasing the stiffness
of the dermal substrate might increase the stiffness sensed by basal
as well as suprabasal epidermal cells resulting in increased JNK
activity and decreased AJ formation in those layers.
To test this hypothesis, we increased the stiffness of the dermal
matrix using a natural crosslinker, genipin, which has been used
previously to crosslink substrates without toxic effects on the cells.
Fig. 5A shows images of crosslinked (dark blue) and control
acellular dermis. After degassing and rehydration for 24 hours, the
Young’s modulus of genipin-crosslinked dermis was 4264 MPa,
which is about threefold higher than control dermis (1362 MPa)
as measured by uniaxial tensile testing (Fig. 5B). After one week
of culture at the air-liquid interface, the thickness of bioengineered
epidermis was similar on treated and untreated dermis as
demonstrated by H&E staining (Fig. 5C,D).
Interestingly, expression of PCNA, p-JNK, and p-c-Jun
extended to the upper suprabasal layers of the epidermis grown
on genipin-crosslinked dermis. Accordingly, the level of E-
cadherin and b-catenin at the cell–cell contact sites was
significantly reduced, even in the upper suprabasal layers
(Fig. 5E). Quantification of the fluorescence intensity showed
that the amount of b-catenin at cell–cell contact sites was
significant lower in the suprabasal layers of bioengineered
Fig. 2. Substrate rigidity regulates JNK
phosphorylation. (A) hKC were plated on plastic
surface, hard PDMS or soft PDMS. Cell lysates were
collected at different time points as indicated and
subjected to western blot for p-JNK and JNK.
(B,C) Normalized levels of p-JNK1 (B) or p-JNK2 (C) on
varying stiffness substrates. The data were further
normalized to the plastic surface at time zero (100%) and
plotted as a function of time (n54); *P,0.05 versus
plastic surface (at the same time point). (D) hKC were
plated on substrates of varying compliance. Cell lysates
were collected after 24 hours and subjected to western
blot for p-JNK and JNK. (E) Lane intensity of p-JNK1 or
p-JNK2 at 24 hours post-seeding was quantified and
normalized to the expression level of total JNK1 or JNK2,
respectively. The data was further normalized to the
corresponding level on plastic (100%; n54). (F) hKC
were plated on plastic, hard PDMS or soft PDMS
substrates. After 24 hours, cell lysates were subjected to
western blot for E-cadherin and b-catenin. b-actin served
as loading control (n54).
Substrate rigidity and AJ formation 2721
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epidermis on genipin-treated dermis, as compared to control
dermis (Fig. 5F). Notably, decreased AJ formation was
accompanied by delayed epidermal differentiation as shown by
immunostaining for K10 (Fig. 5E). These results suggest that the
increased dermal stiffness was experienced not only by the basal
but also suprabasal hKC, leading to increased JNK activity and
decreased AJ throughout the epidermis.
Overexpression of JNK disrupted AJ formation in the
suprabasal epidermal layers
To verify that the disruption of AJ in the suprabasal cells was due
to JNK activation, we generated epidermis with keratinocytes
overexpressing the constitutively active, MMK7-JNK1 fusion
protein under the control of a doxycycline (Dox)-regulatable
promoter. Then MKK7-JNK1 expressing hKC were seeded onto
acellular dermis and expression of MKK7-JNK1 was induced
by addition of Dox on the first day at the air-liquid interface. On
day 7, MKK7-JNK1 cells had formed bioengineered epidermis
of similar thickness as control cells (Fig. 6A,B). Immunostaining
of tissue sections for E-cadherin and b-catenin showed that
MKK7-JNK1 bioengineered epidermis exhibited weak and
disorganized AJ (Fig. 6C). The fluorescence intensity of b-
catenin at the cell–cell contact sites was significantly lower in the
suprabasal layers of MKK7-JNK1 bioengineered epidermis, as
compared with control epidermis (Fig. 6D). In agreement,
staining for p-JNK, p-c-Jun and the proliferation marker PCNA
was extended into the suprabasal layers of MKK7-JNK1
bioengineered epidermis. At the same time, expression of the
differentiation marker K10 was restricted only in the upper
suprabasal layers, suggesting delayed differentiation (Fig. 6C).
Loss of JNK induced AJ formation in the basal epidermal
layer
Next we examined whether eliminating JNK activity was
sufficient to induce AJ formation even on the cells of the basal
epidermal layer. To test the hypothesis, we employed two 3D
model systems: (i) JNK1 and JNK2 knockdown bioengineered
epidermis; and (ii) jnk12/2 and jnk22/2 mice.
First, we prepared bioengineered human epidermis using control
(scramble), shJNK1 or shJNK2 hKC. As shown in Fig. 7A,B,
shJNK1 bioengineered epidermis contained fewer layers of
keratinocytes (shJNK1: 661 versus control: 1262) and was
significantly thinner (shJNK1: 77.762.2 mm versus control:
95.568.5 mm, P,0.05), while shJNK2 epidermis showed similar
layers but was significantly thicker than control (layer of shJNK2:
1362, thickness: 124.6615.5 mm, P,0.05). Accordingly, the
basal hKC layer in shJNK1 tissue equivalents expressed very low
PCNA levels, suggesting low proliferation. In contrast, PCNA
staining in shJNK2 epidermis was higher than control and was
extended to several suprabasal cell layers (Fig. 7C).
Fig. 3. Substrate rigidity regulates AJ formation through JNK. (A) hKC were transduced with a lentiviral vector carrying MKK7-JNK1. Cell lysates were
subjected to western blot for p-JNK, JNK, E-cadherin and b-catenin. b-actin served as loading control. (B) MKK7-JNK1-transduced hKC were cultured on glass,
hard PDMS and soft PDMS in the presence or absence of SP600125 (10 mM, 30 minutes). Cells were immunostained for b-catenin (red) and nucleus was
counterstained with Hoechst dye (blue). View 636. (C) hKC were transduced with a lentiviral vector carrying shRNA targeting the jnk1, jnk2 or jnk1/2 mRNAs.
The cell lysates were subjected to western blot for JNK1, JNK2, b-catenin, and E-cadherin proteins. b-actin served as loading control. (D) hKC (scramble control,
shJNK1, shJNK2 or shJNK1/2) were seeded on glass, hard or soft PDMS. Dash line indicates the colonies. After 24 hours, cells were immunostained for b-catenin
(red) and cell nuclei were counterstained with Hoechst dye (blue). View 636. Scale bars: 10 mm.
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As expected, the levels of p-c-Jun was dramatically reduced in
shJNK1 and shJNK2 KC skin equivalents but there was no
significant difference in the expression of the differentiation
marker K10, which was limited to suprabasal layers similar to
native epidermal tissue (Fig. 7C). Interestingly, both shJNK1 and
shJNK2 bioengineered epidermis exhibited strong AJ throughout
all cell layers including the basal and immediate suprabasal
layers, as indicated by E-cadherin and b-catenin staining
(Fig. 7C). The fluorescence intensity of b-catenin at cell–cell
contact sites was significantly higher in the basal and immediate
suprabasal layers of shJNK1 and shJNK2 bioengineered
epidermis, as compared with control epidermis (Fig. 7D).
Interestingly, increasing the stiffness of acellular dermis by
genipin treatment failed to reverse the phenotype of shJNK
tissues, which exhibited strong AJ throughout the epidermis
including the basal layer (Fig. 7E).
To determine the relevance of our results in vivo, we examined
the epidermis of jnk12/2 and jnk22/2 mice. In agreement with
the knockdown bioengineered epidermis and with previous
reports (Weston et al., 2004), the epidermis of jnk12/2 mice
contained fewer cell layers compared to control tissues (jnk12/2:
361 versus WT: 762 layers, P,0.05) and was significantly
thinner (jnk12/2: 5.060.9 mm versus WT: 8.860.6 mm, P,0.05)
(Fig. 7F,G). On the other hand, the jnk22/2 mouse epidermis
contained similar number of cell layers and it was thicker than
wild type but the difference was not significant (jnk22/2:
9.560.5 mm versus WT: 8.860.6 mm) (Fig. 7F,G). As
expected, the fluorescence intensity of p-c-Jun was absent in
jnk12/2 and jnk22/2 mouse skin as compared to wild-type mouse
epidermis (Fig. 7H). In contrast to native epidermis, both jnk12/2
and jnk22/2 epidermis exhibited strong AJ in all cell layers
including the basal layer (Fig. 7H). In addition, the fluorescence
intensity of b-catenin at the cell–cell contact sites of basal cells
(layer 1) was significantly higher in jnk12/2 and jnk22/2 mice,
compared to wild-type epidermis (Fig. 7I). Collectively, our
results clearly suggest that formation of AJ is regulated by the
activity of JNK, which in turn may be regulated by substrate
stiffness, ultimately resulting in molecular gradients that may
affect tissue stratification and differentiation.
Discussion
Several studies demonstrated that substrate rigidity regulates
cell–cell versus cell–substrate adhesion (Discher et al., 2005;
Tsai and Kam, 2009). In the present study, we applied glass,
plastic and PDMS substrates with varying compliance between
10 and 103 kPa to study the effect of stiffness on formation of AJ
between epidermal keratinocytes. On rigid glass and plastic
surfaces, hKC maintained high levels of JNK activity and spread
well but failed to form colonies. On the other hand, on soft
PDMS substrates, phosphorylation of JNK decreased over time
and cells formed tight colonies within 24 hours. In agreement,
immunostaining showed that on rigid surfaces AJ proteins, E-
cadherin and b-catenin distributed throughout the cell. In
contrast, on soft substrates E-cadherin and b-catenin were
localized at the cell–cell contact sites. However, the total
amounts of E-cadherin and b-catenin per cell remained
unchanged, suggesting that AJ formation on soft substrates did
not result from increased synthesis of AJ proteins. These results
are in agreement with recent studies implicating substrate
stiffness in the disruption of endothelial cell AJ and leading to
vascular pathologies such as enhanced permeability, neutrophil
transmigration or atherosclerosis (Huynh et al., 2011; Krishnan
et al., 2011; Stroka and Aranda-Espinoza, 2011).
Our main finding is that JNK regulates AJ formation in
response to substrate stiffness in 2D and 3D culture systems as
well as in vivo. In vitro we observed that the level of JNK
Fig. 4. JNK phosphorylation correlates negatively with AJ formation
in human epidermis. (A,B) Neonatal human foreskin tissues were
subjected to immunofluorescence staining for (A) K10 (red), PCNA (red),
p-c-Jun (red), p-JNK (green) and (B) E-cadherin (red), b-catenin (green),
a-catenin (red) and F-actin (green). Nuclei were counterstained with
Hoechst dye (blue). Dashed lines indicate the interface between dermis
and epidermis. View 636. (C) Values of fluorescence intensity
(integrated density/area) of b-catenin at cell–cell contact sites or p-JNK in
nucleus as a function of position in the epidermis. Layer 1 indicates the
basal layer. The stratum corneum layers are not included because they do
not contain AJ. The Spearman correlation coefficient (Rs520.89)
denotes a strong negative correlation between p-JNK and b-catenin as a
function of position within the epidermis (n56). Scale bars: 10 mm.
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Fig. 6. Overexpression of JNK disrupts AJ
formation in the suprabasal epidermal
layers. (A) H&E staining of scramble and
MKK7-JNK1 bioengineered epidermis. View
406. (B) The thickness of epidermis in A
(n53). (C) Control (scramble) or MKK7-
JNK1 skin equivalents were subjected to
immunofluorescence staining for E-cadherin
(green), b-catenin (red), K10 (red), PCNA
(green), p-c-Jun (red) and p-JNK (green).
Nuclei were counterstained with Hoechst dye
(blue). View 636. (D) Values of fluorescence
intensity of b-catenin at cell–cell contact sites.
Layer 1 indicates the basal layer. The stratum
corneum layers are not included because they
do not contain AJ (n53); *P,0.05 versus
scramble. Scale bars: 10 mm.
Fig. 5. Substrate mechanics affect JNK activity and AJ formation in 3D tissues. (A) Photographs of decellularized dermis before and after genipin treatment
(blue). (B) Stress-strain relationship of normal and genipin-treated decellularized human dermis as determined by tensile testing. The lines indicate the linear
region that was used to calculate the Young’s modulus (n53). (C) H&E staining of bioengineered skin with normal or genipin-treated dermis. Dashed lines
indicate the interface between dermis and epidermis. View 406. (D) The average thickness of the epidermis in C was determined by dividing the area of the tissue
by the length of the basement membrane underlying the epidermis (n53). (E) The epidermis on normal and genipin-treated dermis were subjected to
immunofluorescence staining for E-cadherin (green), b-catenin (red), K10 (red), PCNA (green), p-JNK (green) and p-c-Jun (red). Nuclei were counterstained with
Hoechst (blue). View 636. (F) Values of fluorescence intensity of b-catenin at cell–cell contact sites. Layer 1 indicates the basal layer. The stratum corneum
layers are not included because they do not contain AJ (n53); *P,0.05 versus normal dermis. Scale bars: 10 mm.
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phosphorylation decreased with decreasing substrate rigidity. On
the softest substrate, JNK phosphorylation was diminished and E-
cadherin and b-catenin translocated to the cell–cell contact sites
forming AJ. This is in agreement with our previous studies
showing that blocking the activity of JNK induced AJ formation
in hKC and other epithelial cell lines (Lee et al., 2009; Lee et al.,
2011). Indeed, knocking down JNK1, JNK2 or both induced AJ
formation even on the hardest substrate, namely the glass surface.
Conversely, overexpressing constitutively active JNK prevented
AJ formation even on the softest PDMS substrate. Taken together
these observations suggest that JNK mediated AJ formation in
epithelial cells in response to substrate compliance.
Fig. 7. Loss of JNK induces AJ formation in the basal epidermal layer. (A) H&E staining of scramble, shJNK1 and shJNK2 skin equivalents. View 406.
(B) The thickness of epidermis in A (n53). (C) Scramble, shJNK1 and shJNK2 epidermal equivalents were immunostained for E-cadherin (green), b-catenin
(red), K10 (red), PCNA (green) and p-c-Jun (red). Nuclei were counterstained with Hoechst dye (blue). View 636. (D) Values of fluorescence intensity of b-
catenin at cell–cell contact sites. Layer 1 indicates the basal layer. The stratum corneum layers are not included because they do not contain AJ (n53). (E) shJNK1
and shJNK2 epidermal equivalents on genipin-treated dermis were immunostained for E-cadherin (green) and b-catenin (red). Nuclei were counterstained with
Hoechst dye (blue). Dashed lines indicate the interface between dermis and epidermis. View 636. (F) H&E staining of wild-type, jnk12/2 or jnk22/2 mouse skin.
View 406. (G) Thickness of wild-type, jnk12/2 or jnk22/2 mouse epidermal tissues (n53). (H) Wild-type, jnk12/2 and jnk22/2 mouse skin tissues were
immunostained for b-catenin (red), p-c-Jun (red) and nuclei were counterstained with Hoechst dye (blue). View 636. (I) Values of fluorescence intensity of b-
catenin at cell–cell contact. Layer 1 indicates the basal layer. The stratum corneum layers are not included because they do not contain AJ (n53). *P,0.05 versus
scramble (B,D) or wild-type (G,I). Scale bars: 10 mm.
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Interestingly, ME180 cells lacking a-catenin did not form
AJ on soft substrates. However, introduction of a-catenin
restored the ability of ME180 cells (a-cat-ME180) to form
substrate-induced AJ. This result is in agreement with recent
work from our laboratory demonstrating that a-catenin was
necessary for AJ formation in response to JNK inhibition by the
chemical inhibitor, SP600125 or by shRNA (Lee et al., 2011).
Notably, the level of p-JNK decreased with decreasing substrate
stiffness even in ME180 cells that could not form AJ, providing
further evidence that JNK inhibition preceded AJ formation. The
upstream JNK effector that may be responsive to substrate
stiffness in epithelial cells remains to be elucidated, but some
studies identified RhoA as substrate-dependent molecular sensor
in human bone marrow-derived mesenchymal stem cells and
fibroblasts (Huynh et al., 2011; Kim et al., 2009; Krishnan et al.,
2011; Paszek et al., 2005; Stroka and Aranda-Espinoza, 2011).
Notably, our in vitro data with different substrates in 2D
cultures were extended in 3D bioengineered epidermis as well as
in vivo, suggesting that the epidermis may be experiencing a
stiffness gradient. This notion is supported by mechanical testing
showing that the major contributor to mechanical integrity of skin
tissue comes from the dermis and hypodermis while the
contribution of the epidermis is small (Hendriks et al., 2003;
Magnenat-Thalmann et al., 2002; Pailler-Mattei et al., 2008).
Therefore, the basal cells may be sensing a more rigid substrate
(dermis) as compared to the suprabasal and granular cells
residing on other, softer epidermal cell layers. This ‘cell-on-cell’
hypothesis was initially proposed by Discher and colleagues who
observed that myotubes attaching on glass showed abundant
stress fibers but myotubes cultured on top of another myotube
layer differentiated into a striated state, presumably because they
perceived a softer substrate (Engler et al., 2004; Griffin et al.,
2004). This stiffness gradient across the epidermal tissue may in
turn be responsible for downregulating JNK phosphorylation
leading to AJ formation in the upper epidermal layers. Indeed, we
observed that JNK was phosphorylated in the basal and
immediate suprabasal layers but not in the upper suprabasal
and granular layers of epidermal tissues (Fig. 4A). In agreement,
integrins e.g. a5 and b1 are expressed in the basal epidermal
layer but are absent in differentiated keratinocytes of the upper
suprabasal layers (Adams and Watt, 1990; Nicholson and Watt,
1991) and significantly downregulated on soft hydrogels (Yeung
et al., 2005). Conversely, the reverse gradient was observed for
AJ, which were either absent or weak in the basal layer but much
stronger in the upper suprabasal layers. Collectively, these data
suggest that the molecular gradients of p-JNK and AJ across the
epidermis might be the result of a stiffness gradient across the
tissue.
To further examine whether substrate stiffness affected JNK
phosphorylation and AJ formation throughout the 3D epidermal
tissues, we increased the stiffness of the dermis by using the
crosslinking agent, genipin. In agreement with previous studies
demonstrating genipin biocompatibility (Tsai et al., 2000), we
found that the crosslinked substrate could be used to generate
bioengineered epidermis of similar thickness as control dermis.
Mechanical measurements showed that crosslinking increased the
dermal substrate stiffness by threefold. We expected that
increased substrate stiffness might increase the stiffness felt not
only by the basal cells but also the suprabasal cells residing on
top of them (Buxboim et al., 2010; Sen et al., 2009). Indeed,
immunostaining showed the presence of p-JNK and p-c-Jun in
the upper suprabasal layers of bioengineered epidermis on
genipin-treated dermis. At the same time, AJ formation
was significantly impaired as indicated by discontinued staining
of E-cadherin and b-catenin throughout the tissue. This result
suggested that in 3D tissues cells on stiff substrates might be
experiencing different rigidity as compared to cells residing on
top of other cells, generating a rigidity gradient. This physical
gradient may give rise to molecular gradients such as JNK
activation and AJ formation, ultimately leading to gradients of
cellular function such as proliferation at the basal layer and cell–
cell adhesion and differentiation in the suprabasal layers.
Similar to cells in culture, JNK mediated the disruption of AJ
in 3D tissues as well. Specifically, expression of constitutively
active JNK by hKC led to AJ dissolution throughout the
bioengineered epidermis, suggesting that JNK activation was
sufficient to disrupt AJ. Conversely, knocking down JNK1 or
JNK2 led to AJ formation even at the basal cell layer, which
typically does not contain AJ. Interestingly, despite having
opposite effects on cell proliferation and epidermal thickness,
shJNK1 or shJNK2 had similar effects on AJ formation. Notably,
the results in bioengineered epidermis were in agreement with
observations in the epidermis of jnk12/2 or jnk22/2 mice. While
jnk12/2 epidermis appeared much thinner than jnk22/2 or control
epidermis, both jnk12/2 and jnk22/2 tissues showed increased
formation of AJ throughout all layers, including the basal cells.
Taking together, these data clearly demonstrate that JNK affects
AJ formation in 3D tissue constructs as well as in vivo, possibly
by sensing a stiffness gradient across tissue layers. However,
other factors that might also influence JNK activity and AJ
formation in vivo, e.g. the reduction of pore size in genipin-
crosslinked ECM scaffolds such as acellular dermis (Trappmann
et al., 2012), nutrient or calcium concentration gradients across
the epidermis cannot be presently excluded.
In agreement with a previous study (Weston et al., 2004),
jnk12/2 mice displayed significantly thinner epidermis, with
markedly reduced proliferation in the basal cell layer.
Differentiation markers, such as keratohyalin granules, loricrin
and keratin 6 were missing in the jnk12/2 mouse skin. On the
other hand, mice lacking JNK2 exhibited epidermal hyperplasia
resulting in thicker epidermal layer containing increased fraction
of p63+ cells. Some differentiation markers such as keratin 10
and keratohyalin granules remained similar to wild-type mice,
while others such as loricrin and keratin 6 were even upregulated
(Weston et al., 2004). Another study documented the differential
effects of JNK1 versus JNK2 on proliferation (Sabapathy et al.,
2004). Various cell types including fibroblasts, erythroblasts and
hepatocytes from jnk22/2 mice were found to exhibit increased
proliferation rates compared to their wild-type counterparts. In
contrast, JNK1 is the positive regulator of c-Jun, and as a result
loss of JNK1 leads to decreased proliferation.
Notably, JNK, an important regulator of cell migration, is
engaged in both focal adhesion and adherens junction processes.
JNK is one of the downstream targets of integrin and focal
adhesion kinase (FAK) (Oktay et al., 1999) and it is known to
phosphorylate serine 178 on paxillin, a focal adhesion adaptor
protein (Huang et al., 2003). Interestingly, on soft substrates hKC
spread much less indicating reduced integrin engagement.
Indeed, FAK phosphorylation also decreased on the hard and
most noticeably on the soft PDMS substrate (supplementary
material Fig. S2), in agreement with previous results (Evans et al.,
2009). On the other hand, our previous findings showed that JNK
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phosphorylated b-catenin and inhibition of JNK activity caused
translocation of the E-cadherin/b-catenin complex to cell–cell
contact sites, leading to formation of AJ (Lee et al., 2009; Lee
et al., 2011). Taken together, these data suggest the hypothesis
that JNK may be a switch regulating the balance between
adherens junctions and focal adhesions. This hypothesis requires
further investigation.
Collectively, our results may have implications in epithelial
tumor development as accumulating evidence suggests that both
tumor cells and their stroma displayed increased stiffness as
compared to their normal counterparts (Levental et al., 2009;
Paszek et al., 2005; Samuel et al., 2011). Stiff stroma was shown
to drive focal adhesions, disrupt AJ, perturb tissue polarity, and
promote growth and malignant behavior both in vitro and in vivo
(Ng and Brugge, 2009; Paszek et al., 2005). JNK has also been
implicated in several cancers including melanoma, head and
neck, breast, gastric and ovarian cancers (Alexaki et al., 2008;
Potapova et al., 2000a; Potapova et al., 2000b; Shibata et al.,
2008; Yang et al., 2003); while chemical inhibition of JNK
inhibited growth of head and neck squamous cell carcinoma
(Gross et al., 2007) and ovarian cancer (Vivas-Mejia et al., 2010).
Finally, in many epithelial tumors such as gastric, breast,
pancreatic and ovarian cancers, E-cadherin expression was
partially or completely lost as they moved towards malignancy
(Berx and van Roy, 2009). Taken together our data may provide
the missing link between substrate stiffness and cancer
progression from benign to malignant through substrate-
mediated activation of JNK, ultimately leading to loss of AJ
and acquisition of metastatic phenotype. More work is required to
address this interesting hypothesis.
Materials and Methods
Materials
The antibody for K10 was purchased from Abcam (Cambridge, MA). SP600125
was purchased from Enzo Life Sciences INC. (Plymouth Meeting, PA). E-
cadherin, b-catenin, JNK, p-c-Jun, FAK (Tyr397), and FAK antibodies were
from Cell Signaling (Danvers, MA). Type I collagen and p-JNK (Thr183/
Tyr185) antibodies were from BD Biosciences (San Jose, CA). JNK1 and JNK2
antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Genipin,
FluoroTagTM FITC Conjugation Kit, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), and b-actin antibody were purchased
from Sigma-Aldrich (St. Louis, MO). The antibody for Proliferating Cell
Nuclear Antigen (PCNA) was from BioLegend (San Diego, CA). Hoechst
33342, Alexa FluorH 488 Phalloidin and Alexa FluorH 488/594 Goat Anti-
Rabbit/Mouse IgG (H+L) antibodies were from Life Technologies (Grand Island,
NY). Polydimethylsiloxane (PDMS) substrates were produced with the
SYLGARDH 184 silicone elastomer kit from Dow Corning Corporation
(Midland, MI). Wild-type, jnk12/2 and jnk22/2 mice were generated as
described previously (Dong et al., 1998; Yang et al., 1998).
PDMS preparation
PDMS substrates of variable stiffness were fabricated using the SYLGARDH 184
silicone elastomer kit as per the manufacturer’s instructions with curing ratios
(polymer to crosslinker): 9:1(hard), 11.5:1 (medium 1), 24:1 (medium 2) or 49:1
(soft) (v/v). Mixed and degassed solutions were then poured into 6-well plates to a
depth of at least 1 mm and cured at 45 C˚ for 24 hours. Cured PDMS preparations,
non-tissue culture plastic surface and glass surface were coated with type I
collagen (0.05 mg/ml) for 12 hours at 4 C˚ followed by UV treatment for 4 hours.
Before seeding cells, collagen-coated surfaces were washed with PBS twice.
MTT assay
hKC (20,000 cells/well) were seeded on plastic surface or PDMS substrates
polymerized in 96-well plates. After 0.5, 2, 6, and 24 hours the medium was
replaced with 200 ml of fresh medium containing 1 mg/ml of MTT. After 1 hour
of incubation at 37 C˚, the MTT-containing medium was removed, and the reduced
formazan dye was solubilized by adding 100 ml of DMSO to each well. After
gentle mixing, the absorbance was measured at 570 nm using a multi-well plate
reader (SYNERGY 4, BioTek, Winooski, VT).
Cell culture and bioengineered skin equivalents
hKC were isolated from neonatal human foreskins, as described before (Koria and
Andreadis, 2006) and cultured in serum free medium (EpiLifeH Medium with
60 mM calcium, Life Technologies). ME180 cells were cultured and passaged
routinely in DMEM supplemented with 10% FBS.
To obtain decellularized human dermis (DED), human cadaver skin was subjected
to three freeze/thaw cycles: 10 minutes in liquid nitrogen followed by 30 minutes at
37 C˚. After three washes in PBS, the skin was incubated in an antibiotic cocktail
containing 0.1 mg/ml of Gentamycin, 10 mg/ml of Ciprofloxacin, 100 units/ml of
penicillin, 100 mg/ml of streptomycin, and 0.25 mg/ml of amphotericin B at 37 C˚.
One week later, the epidermis was peeled off, and the DED was incubated in fresh
antibiotic cocktail at 4 C˚ for four weeks before use (Medalie et al., 1997; Andreadis
et al., 2001). Bioengineered skin equivalents were prepared as described previously
(Andreadis et al., 2001). Briefly, hKC growing on mouse fibroblast feeder layer
(3T3/J2, ATCC, Manassas, VA) were seeded onto acellular dermis and raised to the
air-liquid interface for 7 days.
Crosslinking acellular dermis
To prepare tissue engineered skin, the DED was cut into 1 cm2 square pieces and
were treated with genipin (0.5% w/v in PBS) at room temperature for 96 hours.
Control pieces were soaked in PBS without genipin for the same amount of time.
Following treatment with genipin, DED pieces were washed extensively with PBS,
degassed to remove genipin that was trapped within the pores of the material and
rehydrated in PBS before use.
Lentiviral expression constructs
shRNA targeting the jnk1, jnk2, and jnk1/2 mRNAs (target sequence: jnk1: 59-
GGGCCTACAGAGAGCTAGTTCTTAT-39, jnk2: 59-GCCAACTGTGAGGAA-
TTATGTCGAA-39, jnk1/2:59-AAAGAAUGUCCUACCUUCU-39) was cloned
downstream of the H1 promoter between the MluI and ClaI sites of the
pLVTHM lentiviral vector (Wiznerowicz and Trono, 2003). This vector also
encodes for EGFP under the EF1a promoter, which was used to select for shRNA
expressing cells using flow cytometry (Lee et al., 2009). A fusion protein of JNK
and its upstream activator MKK7 was cloned in downstream of the CMV promoter
between AgeI and MluI sites of the p-TRIP-Z vector (Open Biosystems, Huntsville,
AL). Cells were selected by puromycin treatment and doxycycline (1 mg/ml) was
used to induce MKK7-JNK1 protein expression.
Mechanical characterization of PDMS and DED
PDMS thin strips (,40 mm65 mm61 mm) and DED strips (,20 mm6
5 mm62 mm) were subjected to uniaxial testing using Instron 3343 (InstronH,
Norwood, MA) equipped with 50N load cell. The data were analyzed using
BluehillH 3 software and the elastic modulus was determined from the slope of the
linear part of the stress-strain curves.
Immunoblotting
Cells lysates were prepared essentially as described previously (You and
Laychock, 2009). Equal amounts of protein per sample (30–40 mg) for each
experiment were separated on 8% SDS-PAGE gels and transferred to PVDF
(0.45 mm) membranes. Immunoblotting was carried out essentially as described
previously (You and Laychock, 2009). PVDF membranes were incubated with
primary antibodies (p-JNK, JNK, JNK1, JNK2, E-cadherin, b-catenin, p-FAK,
FAK, and b-actin; dilution 1:1000) for overnight at 4 C˚, and horseradish
peroxidase (HRP)-conjugated anti-rabbit/mouse IgG secondary antibody
(dilution 1:1000) for 1 hour at room temperature.
Immunofluorescence and confocal microscopy
hKC and ME180 cells or tissue sections (paraffin-embedded or OCT-embedded
cryosections) of human neonatal foreskin, mouse skin or bioengineered skin were
fixed with paraformaldehyde (4% w/v) and permeabilized with (0.1% v/v) Triton
X-100. After incubation with blocking buffer (5% v/v goat serum in PBS), samples
were incubated with the primary antibodies against: E-cadherin, b-catenin, K10,
PCNA, p-c-Jun, p-JNK, a-catenin (dilution 1:100 in blocking buffer) or Alexa
FluorH 488 phalloidin (dilution 1:40 in blocking buffer) overnight at 4 C˚. Cells or
tissues were washed at least three times and treated with secondary antibodies:
Alexa FluorH 488 goat anti-rabbit/mouse IgG (H+L) (1:200 dilution) or Alexa
FluorH 594 goat anti-rabbit/mouse IgG (H+L) (1:400 dilution) for 1 hour at room
temperature. Samples were imaged with Zeiss AxioObserver.Z1 fluorescence
microscope equipped with a digital camera (ORCA-ER C4742-80; Hamamatsu,
Bridgewater, NJ) or confocal microscope (LSM 510; Zeiss, Oberkochen,
Germany) equipped with a digital camera. Finally, images were analyzed using
the ImageJ software.
Analysis of fluorescence intensity of human neonatal foreskin, mouse skin
and human bioengineered skin tissues sections
Since the thickness of the epidermis and cell orientation may vary from point to
point within the tissue, the following procedure was used to quantify fluorescence
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intensity at each cell layer. First, a box was set such that it was perpendicular to the
stratum corneum layer and its width was about the same as the width of a cell. In
each cell within the box, two circles were manually drawn, one corresponding to
the nucleus (blue, Hoechst) and the other surrounding the cell membrane (green, b-
catenin) and measured the fluorescence intensity and area between the two circles.
The fluorescence intensity between two cells (i.e. at the junction) was assigned to
both cells. These measurements did not include the stratum corneum, which is
composed of cornified, non-living cells.
Statistical analysis
All statistical analysis was performed using the Statmost statistical analysis
software (Dataxiom Software Inc., Los Angeles, CA). Values are means 6 s.e.m.
Significant differences between treatment groups were determined by Student’s t-
test (paired, two-tailed) or one-way analysis of variance (ANOVA) with post-hoc
analysis using Student–Newman–Keuls multiple comparison test or Spearman
correlations analysis. Values of P#0.05 were accepted as significant.
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